LCTX — Lineage Cell Therapeutics Inc
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Lineage Cell Therapeutics Inc (LCTX), worth $1.80M combined. Over the quarter 1 opened or added, 1 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $1.76M | 0.00% | -36.7% |
| Chapin Davis | $26.24K | 0.00% | NO CHANGE |
| Quadrature | $13.16K | 0.00% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.